Acute variceal bleeding

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 1, 2012, Pages 46-54

  García Pagán, Juan Carlos ^a,b,c   Reverter, Enric ^a,b,c   Abraldes, Juang ^a,b,c   Bosch, Jaime ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

cirrhosis; endoscopic band ligation; portal hypertension; sclerotherapy; somatostatin; terlipressin; tips; variceal bleeding

Indexed keywords

CEFTRIAXONE; CYANOACRYLATE; GLYCERYL TRINITRATE; NORFLOXACIN; OCTREOTIDE; PLASMA SUBSTITUTE; QUINOLONE DERIVATIVE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SOMATOSTATIN; TERLIPRESSIN; VASOPRESSIN;

ABDOMINAL PAIN; AIRWAY DYNAMICS; ARTICLE; BACTERIAL PERITONITIS; BLOOD TRANSFUSION; CAUSE OF DEATH; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ENDOTAMPONADE; ENDOTRACHEAL INTUBATION; ESOPHAGUS VARICES BLEEDING; EXSANGUINATION; FLUID RESUSCITATION; HEART MUSCLE ISCHEMIA; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; HYPOVOLEMIC SHOCK; INCIDENCE; INTENSIVE CARE UNIT; INTESTINE ISCHEMIA; KIDNEY FAILURE; LIGATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDICAL CARE; MEDICAL DECISION MAKING; MORTALITY; NAUSEA; PATIENT IDENTIFICATION; PERIPHERAL ISCHEMIA; PNEUMONIA; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT; STOMACH VARICES; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT FAILURE; URINARY TRACT INFECTION; VOMITING;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BLOOD TRANSFUSION; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RECURRENCE; SHOCK; VASOCONSTRICTOR AGENTS;

EID: 84858744289     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1301734     Document Type: Article

References (86)

1. D'Amico G. Esophageal varices: from appearance to rupture; natural history and prognostic indicators. In: Groszmann RJ, Bosch J., eds. Portal Hypertension in the 21st Century. Dordrecht Kluwer Academic: 2004; 147 154
2. Christensen E, Fauerholdt L, Schlichting P, Juhl E, Poulsen H, Tygstrup N. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology: 1981; 81 5 944 952 (Pubitemid 12232076)
3. D'Amico G, Luca A. Natural history: clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol: 1997; 11 2 243 256 (Pubitemid 27460185)
4. de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis: 2001; 5 3 645 663 (Pubitemid 32847054)
5. Merli M, Nicolini G, Angeloni S., et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol: 2003; 38 3 266 272 (Pubitemid 36286538)
6. Groszmann RJ, Garcia-Tsao G, Bosch J., et al. Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med: 2005; 353 21 2254 2261 (Pubitemid 41697288)
7. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis: 1999; 19 4 475 505 (Pubitemid 30032646)
8. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med: 1988; 319 15 983 989
9. D'Amico G, De Franchis R.; Cooperative Study Group. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology: 2003; 38 3 599 612 (Pubitemid 37052147)
10. de Franchis R.; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol: 2010; 53 4 762 768
11. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology: 1981; 80 4 800 809 (Pubitemid 11137765)
12. Chalasani N, Kahi C, Francois F., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol: 2003; 98 3 653 659 (Pubitemid 36348540)
13. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology: 1995; 108 6 1828 1834
14. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology: 1998; 27 5 1207 1212 (Pubitemid 28227845)
15. Abraldes JG, Villanueva C, Baares R., et al. Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol: 2008; 48 2 229 236
16. Moitinho E, Escorsell A, Bandi JC., et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology: 1999; 117 3 626 631 (Pubitemid 29409248)
17. Monescillo A, Martnez-Lagares F, Ruiz-del-Arbol L., et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology: 2004; 40 4 793 801 (Pubitemid 39288111)
18. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lvy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology: 2004; 40 3 652 659 (Pubitemid 39265587)
19. Augustin S, Muntaner L, Altamirano JT., et al. Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol: 2009; 7 12 1347 1354
20. Augustin S, Altamirano J, Gonzlez A., et al. Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding. Am J Gastroenterol: 2011; 106 10 1787 1795
21. Nidegger D, Ragot S, Berthelmy P., et al. Cirrhosis and bleeding: the need for very early management. J Hepatol: 2003; 39 4 509 514 (Pubitemid 37204649)
22. Crdenas A, Gins P, Uriz J., et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology: 2001; 34 4 Pt 1 671 676 (Pubitemid 32927990)
23. Blei AT, Crdoba J.; Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol: 2001; 96 7 1968 1976 (Pubitemid 32660887)
24. Katon RM. Complications of upper gastrointestinal endoscopy in the gastrointestinal bleeder. Dig Dis Sci: 1981; 26 7, Suppl 47S 54S (Pubitemid 11024932)
25. Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology: 1986; 90 5 Pt 1 1232 1240 (Pubitemid 16145489)
26. Castaeda B, Morales J, Lionetti R., et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology: 2001; 33 4 821 825 (Pubitemid 32246630)
27. Villanueva C, Ortiz J, Miana J., et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology: 2001; 121 1 110 117 (Pubitemid 32591520)
28. Morales J, Moitinho E, Abraldes JG, Fernndez M, Bosch J. Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats. Hepatology: 2003; 38 6 1378 1383 (Pubitemid 37466963)
29. Tripodi A, Primignani M, Chantarangkul V., et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology: 2009; 137 6 2105 2111
30. Ejlersen E, Melsen T, Ingerslev J, Andreasen RB, Vilstrup H. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol: 2001; 36 10 1081 1085 (Pubitemid 32801695)
31. Bosch J, Thabut D, Bendtsen F., et al. European Study Group on rFVIIa in UGI Haemorrhage. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology: 2004; 127 4 1123 1130 (Pubitemid 39345881)
32. Bosch J, Thabut D, Albillos A., et al. International Study Group on rFVIIa in UGI Hemorrhage. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology: 2008; 47 5 1604 1614 (Pubitemid 351702743)
33. Hou MC, Lin HC, Liu TT., et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology: 2004; 39 3 746 753
34. Bernard B, Grang JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology: 1999; 29 6 1655 1661 (Pubitemid 29247035)
35. Rimola A, García-Tsao G, Navasa M., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol: 2000; 32 1 142 153 (Pubitemid 30039459)
36. Fernndez J, Ruiz del Arbol L, Gmez C., et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology: 2006; 131 4 1049 1056, quiz 1285
37. Villanueva C, Ortiz J, Sbat M., et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology: 1999; 30 2 384 389 (Pubitemid 29357501)
38. Baares R, Albillos A, Rincn D., et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology: 2002; 35 3 609 615 (Pubitemid 34183965)
39. Escorsell A, Bandi JC, Moitinho E., et al. Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol: 1997; 26 3 621 627 (Pubitemid 27112728)
40. Escorsell A, Ruiz del Arbol L, Planas R., et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology: 2000; 32 3 471 476
41. Ioannou GN, Doust J, Rockey DC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther: 2003; 17 1 53 64 (Pubitemid 36140434)
42. Uriz J, Gins P, Crdenas A., et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol: 2000; 33 1 43 48 (Pubitemid 30418933)
43. Sol E, Lens S, Guevara M., et al. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology: 2010; 52 5 1783 1790
44. Tydn G, Sammegrd H, Thulin L, Friman L, Efendi S. Treatment of bleeding esophageal varices with somatostatin. N Engl J Med: 1978; 299 26 1466 1467 (Pubitemid 9192312)
45. Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology: 1981; 80 3 518 525 (Pubitemid 11183953)
46. Moitinho E, Planas R, Baares R., et al. Variceal Bleeding Study Group. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol: 2001; 35 6 712 718 (Pubitemid 34717661)
47. Chen L, Groszmann RJ. Blood in the gastric lumen increases splanchnic blood flow and portal pressure in portal-hypertensive rats. Gastroenterology: 1996; 111 4 1103 1110 (Pubitemid 26327614)
48. McCormick PA, Jenkins SA, McIntyre N, Burroughs AK. Why portal hypertensive varices bleed and bleed: a hypothesis. Gut: 1995; 36 1 100 103
49. Abraldes JG, Bosch J. Somatostatin and analogues in portal hypertension. Hepatology: 2002; 35 6 1305 1312 (Pubitemid 34966884)
50. Escorsell A, Bordas JM, del Arbol LR., et al. Variceal Bleeding Study Group. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. J Hepatol: 1998; 29 5 779 788 (Pubitemid 28505935)
51. Escorsell A, Bandi JC, Andreu V., et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology: 2001; 120 1 161 169 (Pubitemid 32061880)
52. Burroughs AK.; International Octreotide Varices Study Group. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial failures. Hepatology: 1996; 24 352A
53. Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology: 2001; 120 4 946 954 (Pubitemid 32193191)
54. Hsu YC, Chung CS, Tseng CH., et al. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol: 2009; 24 7 1294 1299
55. Cheung J, Soo I, Bastiampillai R, Zhu Q, Ma M. Urgent vs. non-urgent endoscopy in stable acute variceal bleeding. Am J Gastroenterol: 2009; 104 5 1125 1129
56. Villanueva C, Piqueras M, Aracil C., et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol: 2006; 45 4 560 567 (Pubitemid 44307385)
57. Lo GH, Lai KH, Cheng JS., et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology: 1995; 22 2 466 471
58. Abraldes JG, Angermayr B, Bosch J. The management of portal hypertension. Clin Liver Dis: 2005; 9 4 685 713, vii (Pubitemid 41406395)
59. Avgerinos A, Armonis A, Stefanidis G., et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology: 2004; 39 6 1623 1630 (Pubitemid 38702663)
60. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet: 1995; 346 8979 865 868
61. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet: 1997; 350 9090 1495 1499 (Pubitemid 28036552)
62. Cals P, Masliah C, Bernard B., et al. French Club for the Study of Portal Hypertension. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med: 2001; 344 1 23 28 (Pubitemid 32064841)
63. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology: 1995; 22 1 332 354
64. Pans J, Ters J, Bosch J, Rods J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices: results in 151 consecutive episodes. Dig Dis Sci: 1988; 33 4 454 459
65. Avgerinos A, Armonis A. Balloon tamponade technique and efficacy in variceal haemorrhage. Scand J Gastroenterol Suppl: 1994; 207 11 16
66. Ters J, Cecilia A, Bordas JM, Rimola A, Bru C, Rods J. Esophageal tamponade for bleeding varices: controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology: 1978; 75 4 566 569 (Pubitemid 9003850)
67. Hubmann R, Bodlaj G, Czompo M., et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy: 2006; 38 9 896 901 (Pubitemid 44430687)
68. Zehetner J, Shamiyeh A, Wayand W, Hubmann R. Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc: 2008; 22 10 2149 2152
69. Wright G, Lewis H, Hogan B, Burroughs A, Patch D, O'Beirne J. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc: 2010; 71 1 71 78
70. Boyer TD, Henderson JM, Heerey AM., et al. DIVERT Study Group. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol: 2008; 48 3 407 414 (Pubitemid 351215203)
71. Bosch J. Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving? J Hepatol: 2001; 35 5 658 660
72. Escorsell A, Baares R, García-Pagán JC., et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology: 2002; 35 2 385 392 (Pubitemid 34106379)
73. Patch D, Nikolopoulou V, McCormick A., et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol: 1998; 28 3 454 460 (Pubitemid 28133550)
74. García-Pagán JC, Caca K, Bureau C., et al. Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med: 2010; 362 25 2370 2379
75. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology: 1992; 16 6 1343 1349
76. Sarin SK, Agarwal SR. Gastric varices and portal hypertensive gastropathy. Clin Liver Dis: 2001; 5 3 727 767, x (Pubitemid 32847058)
77. Huang YH, Yeh HZ, Chen GH., et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc: 2000; 52 2 160 167
78. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology: 2001; 33 5 1060 1064
79. Tan PC, Hou MC, Lin HC., et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology: 2006; 43 4 690 697
80. Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol: 2002; 97 4 1010 1015 (Pubitemid 34408262)
81. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. "Salvageo" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology: 1998; 114 5 981 987 (Pubitemid 28217564)
82. Barange K, Pron JM, Imani K., et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology: 1999; 30 5 1139 1143 (Pubitemid 29510850)
83. Mahadeva S, Bellamy MC, Kessel D, Davies MH, Millson CE. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol: 2003; 98 12 2688 2693 (Pubitemid 38020109)
84. Lo GH, Liang HL, Chen WC., et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy: 2007; 39 8 679 685
85. Procaccini NJ, Al-Osaimi AM, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc: 2009; 70 5 881 887
86. Matsumoto A, Hamamoto N, Nomura T., et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol: 1999; 94 3 643 649 (Pubitemid 29124860)